Cited by 255Smoking Behavior and CessationSubstance Abuse Treatment and OutcomesPrenatal Substance Exposure Effects

Recommendation for the assessment of tobacco craving and withdrawal in smoking cessation trials

Shiffman, Saul, West, Robert, Gilbert, David·2004·Nicotine & Tobacco Research

Abstract

This paper addresses methodological issues in the assessment of nicotine withdrawal and craving in clinical trials of smoking cessation therapies. We define withdrawal as a syndrome of behavioral, affective, cognitive, and physiological symptoms, typically transient, emerging upon cessation or reduction of tobacco use and causing distress or impairment of behavioral function. Offset effects (effects related to removal of a direct nicotine effect) are sustained effects of cessation or reduction of tobacco use that cause distress or impairment. Withdrawal and craving are important as potential predictors of relapse, as mediators and markers of treatment effects, and as clinical phenomena in their own right. Symptoms recommended for assessment include craving, irritability, depression, restlessness, sleep disturbance, difficulty concentrating, increased appetite, and weight gain; anxiety deserves further study. We recommend reporting of data on each of these individual symptoms, and use of multiple-item assessments. Although some standardized measures of withdrawal have promising psychometric properties, no measure has yet fully established its reliability, validity, and broad applicability and, therefore, we do not currently favor universal adoption of any one measure. Assessment of objective indices of withdrawal (e.g., hormonal changes) is currently technically challenging and of unknown value. Although weekly assessment may suffice in some large trials, more intensive measurement can provide better sensitivity. Analyses of withdrawal should include baseline measures and be sensitive to potential instability in baseline. Analytic approaches should take into account potential bias when only abstinent subjects are examined. Conversely, heterogeneity should be considered when smoking subjects are included in intent-to-treat analyses. Withdrawal data from clinical trials focused on assessing abstinence rates may be biased because of progressive subject loss to dropout and relapse; different designs and approaches are needed to investigate the process and natural history of craving and withdrawal.

Integrity signals

Registry

Crossref · 10.1080/14622200410001734067

Cites

Statistics

Recomputing p-values needs the paper’s full text.

Claims the paper makes

This paper’s full text isn’t openly available, so its claims and self-check weren’t run. The registry and citation checks still apply.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

  • Withdrawal following smoking cessation is acutely associated with heightened levels of stress and negative affect.

    “Withdrawal following smoking cessation is acutely associated with heightened levels of stress and negative affect (Shiffman 2004; West 2017).”

    From Mindfulness for smoking cessation (2022) · cites this paper as Shiffman 2004

  • Early stage acute stress, negative affect, and depression are predictive of relapse.

    “but early stage acute stress, negative affect, and depression are predictive of relapse (Correa‐Fernández 2012; Glassman 1990; Shiffman 2004; Shiffman 2005).”

    From Mindfulness for smoking cessation (2022) · cites this paper as Shiffman 2004

Cited by

Sorted by citations

Authors
Shiffman, S., West, R., & Gilbert, D.
Affiliations
  • University of Pittsburgh (US)
  • St George's, University of London (GB)
  • Southern Illinois University Carbondale (US)
Corresponding author
Shiffman, Saul
Venue
Nicotine & Tobacco Research
Published
2004-08-01
Volume
6
Issue
4
Pages
599-614
ISSN
  • 1462-2203 (ISSN-L)
  • 1469-994X
OpenAlex
W1971596397
Cited by
255
References
0
Citations by year
2026: 6 · 2025: 8 · 2024: 8 · 2023: 9 · 2022: 10 · 2021: 16 · 2020: 7 · 2019: 9 · 2018: 14 · 2017: 8 · 2016: 14 · 2015: 10 · 2014: 9 · 2013: 11 · 2012: 15
FWCI
6.99
Type
journal article
Language
en
Open access
closed
Locations
  • Nicotine & Tobacco Research (publishedVersion)
  • PubMed (publishedVersion)
  • UCL Discovery (University College London) (submittedVersion)
Topics
  • Health Sciences › Medicine › Physiology › Smoking Behavior and Cessation
  • Health Sciences › Medicine › Epidemiology › Substance Abuse Treatment and Outcomes
  • Health Sciences › Medicine › Pediatrics, Perinatology and Child Health › Prenatal Substance Exposure Effects
Keywords
cigarette craving, nicotine withdrawal, smoking cessation, recurrence prediction, reliability and validity, intention-to-treat analysis
MeSH terms
Clinical Trials as Topic, Data Collection, Ganglionic Stimulants, Humans, Nicotine, Terminology as Topic, Patient Dropouts, Recurrence, Research Design, Substance Withdrawal Syndrome, Tobacco Use Disorder, Smoking Cessation, Endpoint Determination

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review